Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell & Gene Therapy
Pharma
As Pfizer bows out, CSL keeps hemophilia gene therapy hopes alive
A small patient population, a wait-and-see attitude and a “fairly significant” infrastructure barrier have slowed CSL's gene therapy rollout.
Angus Liu
Apr 11, 2025 10:32am
Novartis unveils $23B investment to beef up US manufacturing, R&D
Apr 10, 2025 3:18pm
AmplifyBio shutters amid tough cell and gene therapy market
Apr 7, 2025 10:38am
FDA turmoil compounds challenges for cell and gene therapy field
Apr 2, 2025 3:16pm
Artis BioSolutions launches with acquisition of Landmark Bio
Apr 2, 2025 10:22am
CBER chief Peter Marks resigns from FDA
Mar 31, 2025 10:50am
More News
Bluebird bio receives rival M&A bid worth 50% higher
Mar 28, 2025 7:14pm
Bharat makes $75M cell and gene therapy splash: reports
Mar 24, 2025 9:01am
Novartis peels back Zolgensma IT data in older SMA patients
Mar 19, 2025 9:00am
Patient dies after receiving Sarepta's DMD gene therapy Elevidys
Mar 18, 2025 10:34am
See more stories
